₹1,041.7
▼ -1.25 -0.12%
As of 27 Jul 2026 · delayed
NSE Listed
Strides Pharma Science Ltd. (STAR)
Volume: 2,48,700Avg Vol 1W: 1,56,949.6Avg Vol 1M: 1,54,360.3552W Range:₹768.65₹1,231
Key Ratios
Checked 1d agoMarket Cap₹9,621 Cr
Current Price₹1,041.7
Previous Close₹1,042.95
High / Low (52w)₹1,231 / ₹768.65
Volume2,48,700
Avg Vol (1W)1,56,949.6
Avg Vol (1M)1,54,360.35
Stock P/E17
Book Value₹337.15
Dividend Yield49%
ROE17.9%
ROA8.29%
Revenue (TTM)₹4,624 Cr
Revenue Growth17.4%
Profit Margin11.45%
Total Debt₹571 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹61.41
P/B3.1
Debt / Equity0.64
50 DMA₹1,082.38
200 DMA₹967.05
Day change-0.12%
Price Chart
₹1,041.7▲ 9.13% · 1Y
2025-07-292026-07-27
20-day avg volume: 1.5L shares
Pros
- Healthy return on equity of 17.9%.
- Pays a dividend yield of 49.0%.
- Company is almost debt-free.
Cons
- Revenue fell 17% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,054 Cr | ₹1,167 Cr | ₹1,154 Cr | ₹1,190 Cr | ₹1,120 Cr | ₹1,221 Cr | ₹1,195 Cr | ₹1,323 Cr |
| EBITDA | ₹156 Cr | ₹165 Cr | ₹168 Cr | ₹181 Cr | ₹178 Cr | ₹209 Cr | ₹292 Cr | ₹195 Cr |
| Net Profit | ₹3,351 Cr | ₹72 Cr | ₹88 Cr | ₹82 Cr | ₹100 Cr | ₹128 Cr | ₹202 Cr | ₹127 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹551 Cr | ₹556 Cr | ₹4,624 Cr | ₹499 Cr | ₹522 Cr | ₹554 Cr | ₹5,009 Cr | ₹606 Cr |
| EBITDA | ₹56 Cr | ₹58 Cr | ₹669 Cr | ₹47 Cr | ₹55 Cr | ₹162 Cr | ₹874 Cr | ₹53 Cr |
| Net Profit | ₹15 Cr | ₹16 Cr | ₹3,593 Cr | ₹13 Cr | ₹32 Cr | ₹122 Cr | ₹556 Cr | ₹16 Cr |
| EPS | — | — | 390.5 | — | — | — | 60.34 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹7,980 Cr | ₹6,152 Cr | ₹7,015 Cr | ₹6,976 Cr | — | — | ₹6,049 Cr | ₹6,927 Cr |
| Total Liabilities | ₹5,178 Cr | ₹3,557 Cr | ₹4,201 Cr | ₹4,593 Cr | — | — | ₹3,462 Cr | ₹3,778 Cr |
| Equity | ₹2,802 Cr | ₹2,595 Cr | ₹2,814 Cr | ₹2,383 Cr | — | — | ₹2,586 Cr | ₹3,149 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹116 Cr | ₹250 Cr | ₹325 Cr | ₹-260 Cr | ₹-43 Cr | ₹677 Cr | ₹617 Cr | ₹774 Cr |
| Investing | ₹-148 Cr | ₹1,306 Cr | ₹-521 Cr | ₹-119 Cr | ₹302 Cr | ₹-150 Cr | ₹-90 Cr | ₹-173 Cr |
| Financing | ₹194 Cr | ₹-1,709 Cr | ₹-16 Cr | ₹421 Cr | ₹-214 Cr | ₹-693 Cr | ₹-643 Cr | ₹-453 Cr |
| Free Cash Flow | ₹116 Cr | ₹100 Cr | ₹27 Cr | ₹-404 Cr | ₹-138 Cr | ₹559 Cr | ₹617 Cr | ₹774 Cr |
Shareholding
Promoter 30.83% Institutions 29.13% Public 40.04%
Efficiency & Working Capital
ROCE17.3%
Interest Coverage4.8
Dividend Payout—
Debtor Days97 d
Inventory Days123 d
Payable Days98 d
Cash Conversion Cycle121 d
Working Capital Days220 d
Shareholding Details
As of 2026-06-30
Promoter27.9%
FII28.4%
DII15.4%
Institutions43.8%
Public28.3%
Promoter Pledge38.1%
No. of Shareholders94,856
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.8% | 27.4% | 25.9% | 25.9% | 25.8% | 26.8% | 28.3% | 28.3% | 27.9% | 27.9% | 27.9% | 27.9% |
| FIIs | 17.2% | 19.4% | 24.6% | 26.7% | 30.1% | 28.5% | 28.3% | 28% | 28.5% | 29.5% | 28.7% | 28.4% |
| DIIs | 18.2% | 17.6% | 18% | 18.6% | 18.2% | 16.9% | 13.7% | 13.3% | 13% | 13% | 14.4% | 15.4% |
| Public | 36.8% | 35.6% | 31.5% | 28.9% | 25.8% | 27.8% | 29.7% | 30.4% | 30.6% | 29.6% | 29% | 28.3% |
| Promoter Pledge | 67.4% | 69.2% | 72.7% | 64.7% | 49.2% | 54.3% | 52% | 50.1% | 44.1% | 30.6% | 27.3% | 38.1% |
| No. of Shareholders | 1,01,638 | 91,182 | 84,695 | 91,917 | 96,009 | 1,14,236 | 95,125 | 92,889 | 91,206 | 85,589 | 86,616 | 94,856 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Pronomz Ventures Llp | Shareholding of Promoter and Promoter Group | 19.6% | 1.81 Cr |
| Quant Mutual Fund - Quant Healthcare Fund | Public Shareholding | 5.6% | 51,56,267 |
| Route One Offshore Master Fund, L.p. | Public Shareholding | 5.1% | 46,53,310 |
| Sbi Life Insurance Co. Ltd | Public Shareholding | 4.8% | 43,87,939 |
| Karuna Business Solutions Llp | Shareholding of Promoter and Promoter Group | 3.5% | 32,25,050 |
| Route One Fund I, L.p. | Public Shareholding | 2.2% | 19,97,344 |
| Arun Kumar Pillai | Shareholding of Promoter and Promoter Group | 2% | 18,60,687 |
| Bandhan Nifty Total Market Index Fund | Public Shareholding | 1.6% | 15,02,309 |
| Satpal Khattar | Public Shareholding | 1.6% | 14,74,942 |
| K R Ravishankar | Shareholding of Promoter and Promoter Group | 1.4% | 12,55,593 |
| Abu Dhabi Investment Authority - Monsoon | Public Shareholding | 1.3% | 12,25,663 |
| Authum Investment And Infrastructure Limited | Public Shareholding | 1.3% | 11,75,622 |
| Mukul Mahavir Agrawal | Public Shareholding | 1.1% | 10,28,750 |
| Oman India Joint Investment Fund Ii | Public Shareholding | 1.1% | 10,11,103 |
| Ishares Core Msci Emerging Markets Etf | Public Shareholding | 1.1% | 9,72,207 |
| Agraganya Private Trust (trustee: Barclay Wealth Trustees (i) Pvt Ltd) | Shareholding of Promoter and Promoter Group | 0.3% | 3,00,000 |
| Karuna Family Private Trust (trustee: Barclay Wealth Trustees (i) Pvt Ltd) | Shareholding of Promoter and Promoter Group | 0.2% | 2,10,000 |
| Vineetha Mohanakumar Pillai | Shareholding of Promoter and Promoter Group | 0.2% | 1,90,000 |
| Padmakumar Karunakaran Pillai | Shareholding of Promoter and Promoter Group | 0.2% | 1,86,485 |
| K R Lakshmi | Shareholding of Promoter and Promoter Group | 0.1% | 1,30,482 |
| Sajitha Pillai | Shareholding of Promoter and Promoter Group | 0.1% | 95,000 |
| Rajitha Gopalakrishnan | Shareholding of Promoter and Promoter Group | 0.1% | 60,000 |
| Hemalatha Pillai | Shareholding of Promoter and Promoter Group | 0.1% | 66,760 |
| Aditya Arun Kumar | Shareholding of Promoter and Promoter Group | 0.1% | 58,422 |
| Anuradha K R | Shareholding of Promoter and Promoter Group | 0% | 5,470 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Pronomz Ventures Llp | 86,84,089 | 48% | 2026-06-30 |
| Karuna Business Solutions Llp | 11,18,050 | 34.7% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Arun Kumar | Chairman & Non Executive Dir. | 2025 |
| Badree Komandur | Executive Director / WTD / Managing Director / CEO | 2025 |
| Kausalya Santhanam | Independent Non Exe. Director | 2025 |
| Mukta Malik Arora | Independent Non Exe. Director | 2025 |
| Homi R Khusrokhan | Independent Non Exe. Director | 2025 |
| Ameet Hariani | Independent Non Exe. Director | 2025 |
| Subir Chakraborty | Independent Non Exe. Director | 2025 |
| Aditya Kumar | Non Executive Director | 2025 |
| Manjula Ramamurthy | Company Sec. & Compli. Officer | 2025 |
| VENKATA SEETHARAMA RAJU PAKALAPATI | Executive Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical business | ₹2,153 Cr | 100% |
| Bio-pharmaceutical business | ₹0 Cr | 0% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Africa | ₹3 Cr | 0.1% |
| Australia | ₹64 Cr | 3.1% |
| Asia | ₹1,374 Cr | 66.8% |
| North America | ₹24 Cr | 1.2% |
| Europe | ₹568 Cr | 27.6% |
| India | ₹11 Cr | 0.5% |
| Others | ₹14 Cr | 0.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 218 | 92 | 92 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-31 | Board Meetings | — |
| forthcoming | 2026-07-31 | Dividend (5/- per share) | Final |
| dividend | 2026-07-31 | ₹5 (50%) | Final |
| dividend | 2025-07-22 | ₹4 (40%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 1,945 | 24 | 0 | 24 | 311 | 2,305 |
| 2025 | 3 | 0 | 0 | 2 | 14 | 20 |
| 2025 | 131 | 24 | 0 | 22 | 278 | 455 |
Insider / Designated-Person Trades
16 recent disclosure(s)
PRONOMZ VENTURES LLPAcquisition · 45,450
PRONOMZ VENTURES LLPAcquisition · 53,200
AGRAGANYA PRIVATE TRUSTAcquisition · 3,00,000
PRONOMZ VENTURES LLPAcquisition · 2,91,250
PRONOMZ VENTURES LLPAcquisition · 52,000
Karuna Business Solutions LLPAcquisition · 1,550
Substantial Acquisitions (SAST)
2 disclosure(s)
Release Of Pledge18/03/2024 · —
Pledge09/10/2023 · —
Company Information
🌐 www.strides.com ↗
📍 No 201 Devavrata Sector 17, Vashi, Navi Mumbai, Maharashtra, 400703
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Sathlokhar Synergys E&C Global Ltd.Srivari Spices N Foods LimitedSpandana Sphoorty Financial Ltd Partly PaidupSteel Strips Wheels Ltd.Stallion India Fluorochemicals Ltd.Stanley Lifestyles Ltd.Star Cement LimitedStar Health & Allied Insurance Company Ltd.Star Paper Mills Ltd.Starteck Finance LimitedState Trading Corporation of India Ltd.Steelcast LimitedAll “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search